Clinical Trial

Lung Cancer Clinical Trial 20213178

[LCID Study Number: 20213178]

CliNIcal Utility of ManaGement of Patients witH CT and LDCT Identified Pulmonary Nodules UsinG the Percepta NasAL Swab ClassifiEr (NIGHTINGALE) - Familiarization and Qualification Protocol

The purpose of this study is to familiarize physicians with the Percepta Nasal Swab Laboratory-Developed Test (LDT), and assess specimen collection and integration of the test into the workflow of patient management.

Disease/Condition: Lung Cancer

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

Protocol #: 20213178

Principal Investigator(s): Carla R. Lamb

Study Coordinator(s): Sanjna Das

Trial Phase: Sponsor Initiated Study Observational